"Dr. M. Asif Taqi, MD, FAHA of Vascular Neurology of Southern California in Thousand Oaks is a triple-board certified interventional and stroke neurologist with a background in neurology, vascular/critical care neurology, and neuroendovascular surgery."

During the past decade, Vascular Neurology of Southern California conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vascular Neurology of Southern California" are "Intracranial Aneurysm" (2 trials), "Acute Ischemic Stroke" (1 trials), "Aneurysm" (1 trials), "Cerebral Aneurysm Unruptured" (1 trials) and "Ruptured Aneurysm" (1 trials). Many other conditions were trialed in "Vascular Neurology of Southern California" in a lesser frequency.

Most popular intervention types in "Vascular Neurology of Southern California" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "NeVa Stent Retrievers" (1 trials), "Next Generation Neuroform Stent System" (1 trials) and "Optima Coil System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vascular Neurology of Southern California" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Vascular Neurology of Southern California". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Vascular Neurology of Southern California, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vascular Neurology of Southern California, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".